Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
Stock
BFRIW
BFRIW News & Events
-
Add to Watchlist
Trade BFRIW
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
BFRIW News
BIOFRONTERA INC PLANS TO SUBMIT PHASE 2B DATA FOR AMELUZ PDT TO FDA IN Q3 2026
22h ago
moomoo
BIOFRONTERA INC - AMELUZ PDT SHOWS POSITIVE SAFETY RESULTS IN PHASE 2B TRIAL
22h ago
moomoo
BIOFRONTERA INC - PHASE 2B STUDY DEMONSTRATES SIGNIFICANTLY LOWER INFLAMMATORY ACNE LESIONS WITH AMELUZ PDT
22h ago
moomoo
BIOFRONTERA INC. ANNOUNCES ENCOURAGING PHASE 2B RESULTS FOR CONTINUED DEVELOPMENT OF AMELUZ® PHOTODYNAMIC THERAPY IN TREATING MODERATE TO SEVERE ACNE VULGARIS
22h ago
moomoo
BIOFRONTERA INC ANTICIPATES SUPPLEMENTAL NDA FILING FOR EXTREMITY, NECK, AND TRUNK INDICATION IN Q3 2026
Feb 17 2026
moomoo
BIOFRONTERA INC. REPORTS COMPLETION OF DATABASE LOCK FOR PHASE 1 PHARMACOKINETICS STUDY OF AMELUZ® IN TREATING ACTINIC KERATOSES ON TRUNK AND EXTREMITIES
Feb 17 2026
moomoo
BIOFRONTERA INC - FDA Establishes PDUFA Deadline for September 28, 2026
Feb 11 2026
moomoo
BIOFRONTERA CONFIRMS FDA ACCEPTANCE OF SUPPLEMENTAL NEW DRUG APPLICATION FOR AMELUZ® PDT IN TREATING SUPERFICIAL BASAL CELL CARCINOMA
Feb 11 2026
moomoo
Show More News
BFRIW Events
No data
BFRIW Monitor News
No data
BFRIW Earnings Analysis
No Data
People Also Watch
